Rebalix
UBS · sheet of 10 September 2026
UBS · sheet of 10 September 2026ETF sheet · official issuer and register data
UBS MSCI EM Socially Responsible UCITS ETF USD acc
LU1048313974 · LU1048313974 · USD · domicile Luxembourg
Equity · Emerging markets · Sustainable / ESGSFDR art. 8
Index tracked: MSCI Emerging Markets SRI Low Carbon Select 5% Issuer Capped Total Return Net
- TER
- 0.24%+ trans. 0.04%
- Fund size
- 686 m EUR
- Tracking difference
- −0.28%3-year avg
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Physical (full replication)
- Income
- Accumulating
Launch 11 Jun 2019 · costs from the KID as of 2 Sept 2026 · 0 securities held · 9 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 5 Aug 2026
The Fund is passively managed and will take proportionate exposure on the components of the MSCI Emerging Markets SRI Low Carbon Select 5% Issuer Capped Index (Net Return) using a sampling strategy which invests in a representative sample of constituent stocks of the index selected by the investment manager using quantitative analytical models in a technique known as 'portfolio optimization'. The Index is designed to measure the performance of best-in-class Environmental, Social and Governance ('ESG') companies based across emerging markets while…
Performance since series start (in euro) — base 100
11 Jun 2019 → 8 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +53.8% |
| 3 years | +97.2% |
| 5 years | +64.4% |
| 10 years | series too young |
| Since series start | +102.9% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 23.57% | 18.72% | 18.54% |
| Max drawdown | −12.91% | −17.38% | −34.26% |
| Sharpe | 1.82 | 1.27 | 0.49 |
| Sortino | 2.75 | 1.87 | 0.70 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · LU1048313974 · LU10483139741
RebalixLU1048313974 · LU1048313974 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +35.76% | +36.21% | −0.45% |
| 2024 | +9.49% | +9.72% | −0.22% |
| 2023 | +7.79% | +7.96% | −0.17% |
| 2022 | −21.01% | −20.75% | −0.26% |
| 2021 | −1.10% | −0.56% | −0.54% |
Holdings
Portfolio as declared by the issuer · 31 Jul 2026 · 0 securities · top-10 weight = 31.9%
| Top holdings | Weight |
|---|---|
| 5.3% | |
| 5.2% | |
| 5.0% | |
| 3.5% | |
| 2.4% | |
| 2.2% | |
| 2.2% | |
| 2.1% | |
| 2.0% | |
| 2.0% |
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
MSRUSB · Borsa Italiana (ETFplus)
UETE · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 19 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
Prospectus · www.ubs.com/2/e/files/lux_etf_pe.pdf
The live sheet, always up to date
rebalix.com/en/etf/LU1048313974
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/LU1048313974
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · LU1048313974 · LU10483139742